The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer

被引:73
作者
Beard, Jordan A.
Tenga, Alexa
Chen, Taosheng
机构
[1] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA
[2] Univ Tennessee, Hlth Sci Ctr, Integrated Biomed Sci Program, Memphis, TN 38163 USA
基金
美国国家卫生研究院;
关键词
Nuclear receptor; NR4A; Nur77; Nurr1; Oncogene; Tumour suppressor; ORPHAN NUCLEAR RECEPTOR; HYPOXIA-INDUCIBLE FACTORS; PROTEIN-KINASE B; CELL-DEATH; NGFI-B; HIF-ALPHA; TRANSCRIPTIONAL ACTIVITY; ENDOPLASMIC-RETICULUM; NEGATIVE REGULATION; PROAPOPTOTIC GENES;
D O I
10.1016/j.cellsig.2014.11.009
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Nuclear receptor (NR) subfamily 4 group A (NR4A) is a family of three highly homologous orphan nuclear receptors that have multiple physiological and pathological roles, including some in cancer. These NRs are reportedly dysregulated in multiple cancer types, with many studies demonstrating pro-oncogenic roles for NR4A1 (Nur77) and NR4A2 (Nurr1). Additionally, NR4A1 and NR4A3 (Nor-1) are described as tumor suppressors in leukemia. The dysregulation and functions of the NR4A members are due to many factors, including transcriptional regulation, protein-protein interactions, and post-translational modifications. These various levels of intracellular regulation result from the signaling cross-talk of the NR4A members with various signaling pathways, many of which are relevant to cancer and likely explain the family members' functions in oncogenesis and tumor suppression. In this review, we discuss the multiple functions of the NR4A receptors in cancer and summarize a growing body of scientific literature that describes the interconnectedness of the NR4A receptors with various oncogene and tumor suppressor pathways. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:257 / 266
页数:10
相关论文
共 166 条
[21]
Activation of Nur77 by selected 1,1-bis(3'-indolyl)-1-(p-substituted phenyl) methanes induces apoptosis through nuclear pathways [J].
Chintharlapalli, S ;
Burghardt, R ;
Papineni, S ;
Ramaiah, S ;
Yoon, K ;
Safe, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (26) :24903-24914
[22]
Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-in dependent pathways [J].
Cho, Sung Dae ;
Yoon, Kyungsil ;
Chintharlapalli, Sudhakar ;
Abdelrahim, Maen ;
Lei, Ping ;
Hamilton, Stanley ;
Khan, Shaheen ;
Ramaiah, Shashi K. ;
Safe, Stephen .
CANCER RESEARCH, 2007, 67 (02) :674-683
[23]
Activation of Nerve Growth Factor-Induced Bα by Methylene-Substituted Diindolylmethanes in Bladder Cancer Cells Induces Apoptosis and Inhibits Tumor Growth [J].
Cho, Sung Dae ;
Lee, Syng-Ook ;
Chintharlapalli, Sudhakar ;
Abdelrahim, Maen ;
Khan, Shaheen ;
Yoon, Kyungsil ;
Kamat, Ashish M. ;
Safe, Stephen .
MOLECULAR PHARMACOLOGY, 2010, 77 (03) :396-404
[24]
Nur77 activated by hypoxia-inducible factor-1α overproduces proopiomelanocortin in von Hippel-Lindau-mutated renal cell carcinoma [J].
Choi, JW ;
Park, SC ;
Kang, GH ;
Liu, JO ;
Youn, HD .
CANCER RESEARCH, 2004, 64 (01) :35-39
[25]
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241
[26]
Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function [J].
de Vries, A ;
Flores, ER ;
Miranda, B ;
Hsieh, HM ;
van Oostrom, CTM ;
Sage, J ;
Jacks, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :2948-2953
[27]
MAP kinase signalling pathways in cancer [J].
Dhillon, A. S. ;
Hagan, S. ;
Rath, O. ;
Kolch, W. .
ONCOGENE, 2007, 26 (22) :3279-3290
[28]
Pten is essential for embryonic development and tumour suppression [J].
Di Cristofano, A ;
Pesce, B ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE GENETICS, 1998, 19 (04) :348-355
[29]
Glycogen synthase kinase 3β regulates cyclin D1 proteolysis and subcellular localization [J].
Diehl, JA ;
Cheng, MG ;
Roussel, MF ;
Sherr, CJ .
GENES & DEVELOPMENT, 1998, 12 (22) :3499-3511
[30]
ELDEIRY WS, 1994, CANCER RES, V54, P1169